Pharmacotherapeutic candidates for myopia: A review Post date November 15, 2022 ← Orthokeratology lens-related Acanthamoeba keratitis: case report and analytical review → Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression (LAMP) Study
